Nanotechnology in the COVID-19 Pandemic
Nanotechnology has shown great potential in contributing to the efficient regulation and management of COVID-19. By designing materials with precise structures and molecular architectures, nanoscience enables the development of particles ranging from one nanometer to hundreds of nanometers in size. These nanomaterials exhibit unique optical, electrical, and biological properties due to their nanoscale structure. Given the similar scale of activity between nanoparticles and viruses, nanotechnology offers promising applications in vaccine development and immune system modulation. Researchers in nanomedicine have long studied the ability of various nanosystems and viral vectors to deliver genes, which has informed approaches to combatting high infectivity rates in viruses like SARS-CoV-2.
Key applications of nanotechnology in COVID-19 include:
- Nanotechnology-based vaccines
- Immunization through delivery of viral biomolecules
- Nucleic acid-based nanovaccines